RAFAEL
BAÑARES CAÑIZARES
Catedrático de universidad
![Foto de Manuel de la](/img/nophoto.png)
Manuel de la
Mata García
Publicaciones en las que colabora con Manuel de la Mata García (23)
2024
-
Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure
Digestive and Liver Disease
-
Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysis
Hepatology, Vol. 79, Núm. 3, pp. 624-635
2023
-
Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode
Liver International, Vol. 43, Núm. 7, pp. 1548-1557
2021
-
A simple nomogram identifies patients with refractory ascites with worse outcome after transjugular intrahepatic portosystemic shunt
European journal of gastroenterology & hepatology, Vol. 33, Núm. 1S Suppl 1, pp. e587-e593
-
Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis
Journal of Hepatology, Vol. 75, Núm. 2, pp. 342-350
-
Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data
Gastroenterology, Vol. 160, Núm. 1, pp. 193-205.e10
-
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis
Journal of Hepatology, Vol. 74, Núm. 5, pp. 1097-1108
-
Tacrolimus as an Effective and Durable Second-Line Treatment for Chronic Autoimmune Hepatitis: A Multicentric Study
Digestive Diseases and Sciences, Vol. 66, Núm. 8, pp. 2826-2832
2020
-
Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension
Journal of Hepatology, Vol. 73, Núm. 6, pp. 1415-1424
-
Non-selective beta-blockers impair global circulatory homeostasis and renal function in cirrhotic patients with refractory ascites
Journal of Hepatology, Vol. 73, Núm. 6, pp. 1404-1414
-
Persistence of clinically significant portal hypertension after eradication of hepatitis C virus in patients with advanced cirrhosis
Clinical Infectious Diseases, Vol. 71, Núm. 10, pp. 2726-2729
-
Plasma metabolomic fingerprint of advanced cirrhosis stages among HIV/HCV-coinfected and HCV-monoinfected patients
Liver International, Vol. 40, Núm. 9, pp. 2215-2227
-
Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS
Journal of Hepatology, Vol. 73, Núm. 5, pp. 1082-1091
-
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology
Journal of Hepatology, Vol. 73, Núm. 4, pp. 842-854
2018
-
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study
American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522
2017
-
Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis
Gastroenterology, Vol. 153, Núm. 5, pp. 1273-1283.e1
2016
-
Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma
Hepatology, Vol. 63, Núm. 2, pp. 488-498
-
Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure
Hepatology, Vol. 64, Núm. 4, pp. 1249-1264
2015
-
The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure
Journal of Hepatology, Vol. 62, Núm. 4, pp. 831-840
-
V Reunión de Consenso de la Sociedad Española de Trasplante Hepático sobre receptores de riesgo elevado, escenarios actuales de inmunosupresión y manejo del hepatocarcinoma en espera de trasplante
Cirugia Espanola, Vol. 93, Núm. 10, pp. 619-637